Address	2 Carlson Parkway North Minneapolis Minnesota 55447 United States
Employees	-
Website	http://www.diamedica.com
Updated	09/14/2018
DiaMedica Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. Its products includes DM199 that focused on acute ischemic stroke, and chronic kidney disease; and KLK1 which plays a critical role in the regulation of local blood flow, vasodilation in the body, inflammation, and oxidative stress. The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.